Bethesda, MD, United States of America

Conrad Russell Y Cruz

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Bethesda, MD (US) (2018)
  • Washington, DC (US) (2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Conrad Russell Y Cruz

Introduction

Conrad Russell Y Cruz is an accomplished inventor based in Bethesda, MD. He has made significant contributions to the field of medical technology, particularly in cancer treatment and HIV immunotherapy. With a total of two patents to his name, his work is at the forefront of innovative therapeutic solutions.

Latest Patents

His latest patents include "Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof" and "Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use." The first patent focuses on a combination treatment utilizing Prussian blue nanoparticles alongside immunotherapeutic treatments for cancer, emphasizing stability and effectiveness under various conditions. The second patent addresses the development of modified T cells that can resist HIV infection, providing a promising avenue for immunotherapy against HIV-related complications.

Career Highlights

Conrad currently works at the Children's National Medical Center, where he applies his expertise in developing innovative treatments. His research is pivotal in advancing therapeutic options for patients suffering from cancer and HIV.

Collaborations

He collaborates with notable colleagues, including Catherine M Bollard and Sharon Lam, who contribute to his research endeavors and enhance the impact of his work.

Conclusion

Conrad Russell Y Cruz's innovative patents and research efforts are making a significant difference in the fields of cancer treatment and HIV immunotherapy. His contributions reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…